PharmGen Science

PharmGen Science Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of PharmGen Science (004720.KS) as of Oct 21, 2026 is -4.56 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 85.43 % — a change of -105.34% (lower).

Cash Conversion

-4.56 %

YoY

-105.34%

Last updated:

Cash Conversion Rate (OCF/Net Income) of PharmGen Science is 2025 -4.56 % . Cash Conversion Rate (OCF/Net Income) of PharmGen Science was 2024 85.43 % . It decreases by -105.34% lower compared to the previous year.

The PharmGen Science Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
94.35 KRW
Jan 1, 2019
835.62 KRW
Jan 1, 2020
29.01 KRW
Jan 1, 2021
23.98 KRW
Jan 1, 2022
-1.84 KRW
Jan 1, 2023
89.33 KRW
Jan 1, 2024
85.43 KRW
Jan 1, 2025
-4.56 KRW
The PharmGen Science Cash Conversion history
YEARCash ConversionYoY
-4.56 %-105.34%
85.43 %-4.36%
89.33 %-4,965.68%
-1.84 %-107.66%
23.98 %-17.36%
29.01 %-96.53%
835.62 %+785.65%
94.35 %+121.78%
42.54 %-81.06%
224.63 %+28.23%
175.19 %+298.13%
44.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PharmGen Science Stock analysis

What does PharmGen Science do? PharmGen Science, Inc. develops and produces medicaments including antiepileptic agents, anti-inflammatory agents, antiphlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, and respiratory agents. The company also manufactures over-the-counter (OTC) drugs, obesity drugs, and health food. Additionally, PharmGen Science engages in the manufacturing, wholesale, and retail distribution of functional cosmetics. Its products are distributed within the domestic market and to overseas markets. The company's primary revenue streams come from the sale of its pharmaceutical products and functional cosmetics. Pharmaceutical products include both prescription medications like antiepileptic agents and OTC drugs such as obesity drugs. Functional cosmetics are sold through wholesale and retail channels. The domestic market serves as the main sales channel while international distribution supports global reach. PharmGen Science targets healthcare providers, pharmacies, and consumers for its pharmaceutical products. The domestic market is a key segment for prescription drugs and OTC products. Overseas markets represent an additional segment for both pharmaceuticals and cosmetics. Functional cosmetics are distributed through retail and wholesale channels to end consumers and beauty retailers. PharmGen Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmGen Science stock

Cash Conversion Rate (OCF/Net Income) of PharmGen Science is -4.56 % in 2025.

Cash Conversion Rate (OCF/Net Income) of PharmGen Science changed from 85.43 % to -4.56 %, representing a -105.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) PharmGen Science since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s PharmGen Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — PharmGen Science

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — PharmGen Science